Literatur
- 1
American Diabetes Association, American Academy of Neurology .
Consensus statement: Report and recommendations of the San Antonio conference on diabetic
neuropathy.
Diabetes Care.
1988;
11
592-597
- 2
Vinik A I, Maser R E, Mitchell B D. et al .
Diabetic autonomic neuropathy.
Diabetes Care.
2003;
26
1553-1579
- 3
Pfeifer M A, Weinberg C R, Cook D L. et al .
Autonomic neural dysfunction in recently diagnosed diabetic subjects.
Diabetes Care.
1984;
7
447-453
- 4
Ziegler D, Dannehl K, Mühlen H. et al .
Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis,
vector analysis, and standard tests of heart rate variation and blood pressure responses
at various stages of diabetic neuropathy.
Diabet Med.
1992;
9
806-814
- 5 Haslbeck M, Luft D, Neundörfer B. et al .Diagnose, Therapie und Verlaufskontrolle
der autonomen diabetischen Neuropathie. Evidenzbasierte Diabetes-Leitlinie DDG. Deutsche
Diabetes-Gesellschaft. 1. Auflage 2002
- 6
Maser R E, Mitchell B D, Vinik A I. et al .
The association between cardiovascular autonomic neuropathy and mortality in individuals
with diabetes. A meta-analysis.
Diabetes Care.
2003;
26
1895-1901
- 7
Ewing D J, Campbell I W, Clarke B F.
The natural history of diabetic autonomic neuropathy.
Q J Med.
1980;
49
95-108
- 8
Watkins P J, Mackay J D.
Cardiac denervation in diabetic neuropathy.
Ann Intern Med.
1980;
92
304-307
- 9 Schrödter D. Diabetes mellitus - eine kardiovaskuläre Erkrankung. 1. Auflage. UNI-MED,
Bremen 2002
- 10
Ewing D J, Campbell I W, Clarke B F.
Heart rate changes in diabetes mellitus.
Lancet.
1981;
317
183-186
- 11
DCCT Research Group .
The effect of intensive diabetes therapy on measures of autonomic nervous system function
in the Diabetes Control and Complications Trial (DCCT).
Diabetologia.
1998;
41
416-423
- 12
Kennedy W R, Navarro X, Goetz F C. et al .
Effects of pancreatic transplantation on diabetic neuropathy.
N Engl J Med.
1990;
322
1031-1037
- 13
Kennedy W R, Navarro X, Sutherland D E.
Neuropathy profile of diabetic patients in a pancreas transplantation program.
Neurology.
1995;
45
773-780
- 14
Ewing D J, Campbell I W, Clarke B F.
Mortality in diabetic autonomic neuropathy.
Lancet.
1976;
1
601-603
- 15
Gerritsen J, Dekker J M, TenVoorde B J. et al .
Impaired autonomic function is associated with increased mortality, especially in
subjects with diabetes, hypertension, or a history of cardiovascular disease. The
HOORN Study.
Diabetes Care.
2001;
24
1793-1798
- 16
Navarro X, Kennedy W R, Aeppli D. et al .
Neuropathy and mortality in diabetes: influence of pancreas transplantation.
Muscle Nerve.
1996;
19
1009-1016
- 17
Katz A, Liberty I F, Porath A. et al .
A simple bedside test of 1-minute heart rate variability during deep breathing as
a prognostic index after myocardial infarction.
Am Heart J.
1999;
138
32-38
- 18 Luft D. Praxisleitfaden der diabetischen Polyneuropathie. 1. Auflage. UNI-MED Verlag,
Bremen 2000
- 19
Valensi P, Sachs R N, Harfouche B. et al .
Predictive value of cardiac autonomic neuropathy in diabetic patients with or without
silent myocardial ischemia.
Diabetes Care.
2001;
24
339-343
- 20
O'Brien I A, O'Hare J P, Lewin I G. et al .
The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: a controlled
study based on heart rate variability.
Q J Med.
1986;
61
957-967
- 21
Clarke B F, Ewing D J, Campbell I W.
Diabetic autonomic neuropathy.
Diabetologia.
1979;
17
195-212
- 22
Maser R E, Pfeifer M A, Dorman J S. et al .
Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of
Diabetes Complications Study III.
Arch Intern Med.
1990;
150
1218-1222
- 23
Cohen J A, Jeffers B W, Faldut D. et al .
Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent
diabetes mellitus (NIDDM).
Muscle Nerve.
1998;
21
72-80
- 24
Spallone V, Maiello M R, Cicconetti E. et al .
Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non-insulin-dependent
diabetes.
Diabetes Res Clin Pract.
1997;
34
169-179
- 25
Colhoun H M, Francis D P, Rubens M B. et al .
The association of heart-rate variability with cardiovascular risk factors and coronary
artery calcification: A study in type 1 diabetic patients and the general population.
Diabetes Care.
2001;
24
1108-1114
- 26
Simonson D C.
Etiology and prevalence of hypertension in diabetic patients.
Diabetes Care.
1988;
11
812-827
- 27
Muller J E, Tofler G H, Stone P H.
Circadian variation and triggers of onset of acute cardiovascular disease.
Circulation.
1989;
79
733-743
- 28
The Task Force of the European Society of Cardiology and the North American Society
of Pacing Electrophysiology [ESC and NASPE] .
Heart rate variability - standards of measurement, physiological interpretation, and
clinical use.
Circulation.
1996;
93
1043-1065
- 29
Esperer H D.
Physiologische Grundlagen und pathologische Aspekte der Herzfrequenzvariabilität beim
Menschen.
Herzschr Elektrophys.
1994;
5 (Suppl 2)
1-10
- 30
Karemaker J M, Lie K I.
Heart rate variability: a telltale of health or disease. Editorial.
Eur Heart J.
2000;
21
435-437
- 31
Cheng T O.
Decreased heart rate variability as a predictor for sudden death was known in China
in the third century A.D. Letter to the editor.
Eur Heart J.
2000;
21
2081-2082
- 32
Scherer P.
Parameter der Herzfrequenzvariabilität im Zeitbereich.
Herzschr Elektrophys.
1994;
5
15-18
- 33
Ewing D J, Martyn C N, Young R J. et al .
The value of cardiovascular autonomic function tests: 10 years experience in diabetes.
Diabetes Care.
1985;
8 (Suppl 2)
491-498
- 34
Meesmann M, Boese J, Scharf R.
Vergleich der Methoden zur Bestimmung der Herzfrequenzvariabilität.
Herzschr Elektrophys.
1994;
5 (Suppl 2)
25-29
- 35
Wegschneider K.
Statistische Zeitreihenmodelle und Herzfrequenzvariabilität.
Herzschr Elektrophys.
1994;
5 (Suppl 2)
11-14
- 36
Walbrecht P, Cohen R J.
Estimation of heart rate power spectrum bands from real-world data: dealing with ectopic
beats and noisy data.
Comput Cardiol.
1988;
15
311-314
- 37
Howorka K, Pumprla J, Schabmann A.
Optimal parameters of short-term heart rate spectrogram for routine evaluation of
diabetic cardiovascular autonomic neuropathy.
J Auton Nerv Syst.
1998;
69
104-172
- 38
Bigger Jr J T, Fleiss J L, Rolnitzky L M. et al .
Stability over time of heart period variability in patients with previous myocardial
infarction and ventricular arrhythmias. The CAPS and ESVEM investigators.
Am J Cardiol.
1992;
69
718-723
- 39
Akselrod S, Gordon D, Ubel F A. et al .
Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat
cardiovascular control.
Science.
1981;
213
220-222
- 40
Pomeranz B, Macaulay R J, Caudill M A. et al .
Assessment of autonomic function in humans by heart rate spectral analysis.
Am J Physiol.
1985;
248
H 151-H 153
- 41
Malliani A, Pagani M, Lombardi F. et al .
Cardiovascular neural regulation explored in the frequency domain.
Circulation.
1991;
84
1482-1492
- 42
Rimoldi O, Pierini S, Ferrari A. et al .
Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs.
Am J Physiol.
1990;
258
H 967-H 976
- 43
Montano N, Ruscone T G, Porta A. et al .
Power spectrum analysis of heart rate variability to assess the changes in sympathovagal
balance during graded orthostatic tilt.
Circulation.
1994;
90
1826-1831
- 44
Hayano J, Sakakibara Y, Yamada A. et al .
Acuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects.
Am J Cardiol.
1991;
67
199-204
- 45
Hedman A E, Tahvanainen K U, Hartikainen J E. et al .
Effect of sympathetic modulation and sympatho-vagal interaction on heart rate variability
in anaesthetized dogs.
Acta Physiol Scand.
1995;
155
205-214
- 46
Pagani M, Lombardi F, Guzzetti S. et al .
Power spectral density of heart rate variability as an index of sympatho-vagal interaction
in normal and hypertensive subjects.
J Hypertens Suppl.
1984;
2
S 383-S 385
- 47
Kamath M V, Ghista D N, Fallen E L. et al .
Heart rate variability power spectrogram as a potential noninvasive signature of cardiac
regulatory system response, mechanisms, and disorders.
Heart Vessels.
1987;
3
33-41
- 48
Sroka K.
Vagale Depression und ischämische Herzkrankheit.
Herz Kreisl.
1998;
30
437-443
- 49
Brüggemann T, Weiß D, Andresen D.
Spektralanalyse zur Beurteilung der Herzfrequenzvariabilität.
Herzschr Elektrophys.
1994;
5 (Suppl 2)
19-24
- 50
Bigger Jr J T, Fleiss J L, Steinman R C. et al .
Frequency domain measures of heart period variability and mortality after myocardial
infarction.
Circulation.
1992;
85
164-171
- 51
Pagani M.
Heart rate variability and autonomic diabetic neuropathy.
Diabetes Nutr Metab.
2000;
13
341-346
- 52
Tsuji H, Venditti Jr F J, Manders E S. et al .
Reduced heart rate variability and mortality risk in an elderly cohort.
Circulation.
1994;
90
878-883
- 53
Rathmann W, Ziegler D, Jahnke M. et al .
Mortality in diabetic patients with cardiovascular autonomic neuropathy.
Diabet Med.
1993;
10
664-671
- 54
Wolf M M, Varigos G A, Hunt D. et al .
Sinus arrhythmia in acute myocardial infarction.
Med J Aust.
1978;
2
52-53
- 55
Nolan J, Batin P D, Andrews R. et al .
Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial
(UK-Heart).
Circulation.
1998;
98
1510-1516
- 56
Kleiger R E, Miller J P, Bigger Jr J T. et al .
Decreased heart rate variability and its association with increased mortality after
acute myocardial infarction.
Am J Cardiol.
1987;
59
256-262
- 57
Malik M, Farrell T, Cripps T. et al .
Heart rate variability in relation to prognosis after myocardial infarction: selection
of optimal processing techniques.
Eur Heart J.
1989;
10
1060-1074
- 58
Cripps T R, Malik M, Farrell T G. et al .
Prognostic value of reduced heart rate variability after myocardial infarction: clinical
evaluation of a new analysis method.
Br Heart J.
1991;
65
14-19
- 59
La Rovere M T, Bigger Jr J T, Marcus F I. et al .
Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality
after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial
Infarction) Investigators.
Lancet.
1998;
351
478-484
- 60
Ponikowski P, Anker S D, Chua T P. et al .
Depressed heart rate variability as an independent predictor of death in chronic congestive
heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Am J Cardiol.
1997;
79
1645-1650
- 61
Makikallio T H, Huikuri H V, Hintze U. et al .
Fractal analysis and time- and frequency-domain measures of heart rate variability
as predictors of mortality in patients with heart failure.
Am J Cardiol.
2001;
87
178-182
- 62
Klingenheben T, Credner S, Grönefeld G. et al .
Kardialer autonomer Tonus zur Risikostratifikation nach Myokardinfarkt: Ergebnisse
einer prospektiven Langzeitstudie bei 411 konsekutiven Patienten.
Z Kardiol.
1999;
88
400-409
- 63
De Ferrari G M, Vanoli E, Curcuruto P. et al .
Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic
receptors with oxotremorine.
Am Heart J.
1992;
124
883-890
- 64
Gold D R, Litonjua A, Schwartz J. et al .
Ambient pollution and heart rate variability.
Circulation.
2000;
101
1267-1273
- 65
Roche F, Gaspoz J M, Court-Fortune I. et al .
Screening of obstructive sleep apnea syndrome by heart rate variability analysis.
Circulation.
1999;
100
1411-1415
- 66
Kazuma N, Otsuka K, Matsuoka I. et al .
Heart rate variability during 24 hours in asthmatic children.
Chronobiol Int.
1997;
14
597-606
- 67
Coelho L, Saraiva S, Guimaraes H. et al .
Autonomic function in chronic liver disease assessed by Heart Rate Variability Study.
Rev Port Cardiol.
2001;
20
25-36
- 68
Leicht A S, Allen G D, Hoey A J.
Influence of intensive cycling training on heart rate variability during rest and
exercise.
Can J Appl Physiol.
2003;
28
898-909
- 69
Garet M, Tournaire N, Roche F. et al .
Individual interdependence between nocturnal ANS activity and performance in swimmers.
Med Sci Sports Exerc.
2004;
36
2112-2118
- 70
Agelink M W, Malessa R, Baumann B. et al .
Standardized tests of heart rate variability: normal ranges obtained from 309 healthy
humans, and effects of age, gender, and heart rate.
Clin Auton Res.
2001;
11
99-108
- 71
Ziegler D, Laux G, Dannehl K. et al .
Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility
of spectral analysis, vector analysis, and standard tests of heart rate variation
and blood pressure responses.
Diabet Med.
1992;
9
166-175
- 72
Evans J M, Ziegler M G, Patwardhan A R. et al .
Gender differences in autonomic cardiovascular regulation: spectral, hormonal, and
hemodynamic indexes.
J Appl Physiol.
2001;
91
2611-2618
- 73
Wawryk A M, Bates D J, Couper J J.
Power spectral analysis of heart rate variability in children and adolescents with
IDDM.
Diabetes Care.
1997;
20
1416-1421
- 74
Ziegler D, Gries F A, Spüler M. et al .
The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy
Multicenter Study Group.
J Diabetes Complications.
1992;
6
49-57
- 75
Chessa M, Butera G, Lanza G A. et al .
Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy
in children.
Herz.
2002;
27
785-790
- 76
Levitt N S, Stansberry K B, Wynchank S. et al .
The natural progression of autonomic neuropathy and autonomic function tests in a
cohort of people with IDDM.
Diabetes Care.
1996;
19
751-754
- 77
Howorka K, Pumprla J, Haber P. et al .
Effects of physical training on heart rate variability in diabetic patients with various
degrees of cardiovascular autonomic neuropathy.
Cardiovasc Res.
1997;
34
206-214
- 78
Singh J P, Larson M G, O'Donnell C J. et al .
Association of hyperglycemia with reduced heart rate variability (The Framingham Heart
Study).
Am J Cardiol.
2000;
86
309-312
- 79
DCCT Research Group .
The absence of a glycemic threshold for the development of long-term complications:
the perspective of the Diabetes Control and Complications Trial (DCCT).
Diabetes.
1996;
45
1289-1298
- 80
Gaede P, Vedel P, Larsen N. et al .
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
N Engl J Med.
2003;
348
383-393
- 81
Ziegler D, Schatz H, Conrad F. et al .
Effects of treatment with the antioxidant α-lipoic acid on cardiac autonomic neuropathy
in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study).
Deutsche Kardiale Autonome Neuropathie.
Diabetes Care.
1997;
20
369-373
- 82
Didangelos T P, Karamitsos D T, Athyros V G. et al .
Effect of aldose reductase inhibition on cardiovascular reflex tests in patients with
definite diabetic autonomic neuropathy over a period of 2 years.
J Diabetes Complications.
1998;
12
201-207
- 83
Okamoto H, Nomura M, Nakaya Y. et al .
Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis.
Intern Med.
2003;
42
655-664
- 84
Kontopoulos A G, Athyros V G, Didangelos T P. et al .
Effect of chronic quinapril administration on heart rate variability in patients with
diabetic autonomic neuropathy.
Diabetes Care.
1997;
20
355-361
- 85
Malik R A, Williamson S, Abbott C. et al .
Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic
neuropathy: randomised double-blind controlled trial.
Lancet.
1998;
352
1978-1981
- 86
Ebbehoj E, Poulsen P L, Hansen K W. et al .
Effects on heart rate variability of metoprolol supplementary to on going ACE-inhibitor
treatment in type I diabetic ptients with abnormal albuminuria.
Diabetologia.
2002;
45
965-975
- 87
Schönauer M, Schreiner M, Niebauer J. et al .
Einfluss der Stoffwechselverbesserung unter Pioglitazon auf die Herzfrequenzvariabilität
bei Typ-2-Diabetikern: Ergebnisse der Praxisstudie ETAPP.
Dtsch Ärztebl Thüringen.
2004;
15
340-341
- 88
Boulton A JM, Vinik A I, Arezzo J C. et al .
Diabetic neuropathies, A statement by the American Diabetes Association.
Diabetes Care.
2005;
28
956-962
Dr. M. Schönauer
Diabetologische Schwerpunktpraxis
August-Bebel-Str. 71
04275 Leipzig
Email: mschoenauer@web.de
